Drawing for POLYSYNC

USPTO serial 99466686

POLYSYNC

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
KIM, BARBARA G
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with POLYSYNC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Danielle I Mattessich

Danielle I Mattessich Merchant & Gould P.C.P.O. Box 2910150 S. 5th St., Ste 2200Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
009Software and technology, namely, downloadable software, downloadable software in the nature of a mobile application, and electrodes for use in the diagnosis, monitoring, management, and treatment of obstructive sleep apnea; Software and technology, namely, downloadable software, downloadable software in the nature of a mobile application, and electrodes for use in programming, controlling, operating, and analyzing medical devices and hypoglossal nerve stimulation systems used in the treatment of obstructive sleep apnea; Software and technology, namely, downloadable software, downloadable software in the nature of a mobile application, and electrodes for use in collecting, storing, and reporting patient data, therapy outcomes, and titration results related to obstructive sleep apnea therapy; Software and technology, namely, downloadable software, downloadable software in the nature of a mobile application, and electrodes for use by medical professionals in evaluating, adjusting, and tracking patient therapy and outcomes for obstructive sleep apnea; Software and technology, namely, downloadable software, downloadable software in the nature of a mobile application, and electrodes for use in treating obstructive sleep apneaACTIVE—
010Software and technology, namely, implantable nerve stimulation apparatus incorporating recorded software and medical electrodes for use in the diagnosis, monitoring, management, and treatment of obstructive sleep apnea; Software and technology, namely, implantable nerve stimulation apparatus incorporating recorded software and medical electrodes for use in programming, controlling, operating, and analyzing medical devices and hypoglossal nerve stimulation systems used in the treatment of obstructive sleep apnea; Software and technology, namely, implantable nerve stimulation apparatus incorporating recorded software and medical electrodes for use in collecting, storing, and reporting patient data, therapy outcomes, and titration results related to obstructive sleep apnea therapy; Software and technology, namely, implantable nerve stimulation apparatus incorporating recorded software and medical electrodes for use by medical professionals in evaluating, adjusting, and tracking patient therapy and outcomes for obstructive sleep apnea; Software and technology, namely, implantable nerve stimulation apparatus incorporating recorded software and medical electrodes for use in treating obstructive sleep apneaACTIVE—
042Software and technology, namely, providing online non-downloadable software and providing temporary use of online non-downloadable computer software applications for use in the diagnosis, monitoring, management, and treatment of obstructive sleep apnea; Software and technology, namely, providing online non-downloadable software and providing temporary use of online non-downloadable computer software applications for use in programming, controlling, operating, and analyzing medical devices and hypoglossal nerve stimulation systems used in the treatment of obstructive sleep apnea; Software and technology, namely, providing online non-downloadable software and providing temporary use of online non-downloadable computer software applications for use in collecting, storing, and reporting patient data, therapy outcomes, and titration results related to obstructive sleep apnea therapy; Software and technology, namely, providing online non-downloadable software and providing temporary use of online non-downloadable computer software applications for use by medical professionals in evaluating, adjusting, and tracking patient therapy and outcomes for obstructive sleep apnea; Software and technology, namely, providing online non-downloadable software and providing temporary use of online non-downloadable computer software applications for use in treating obstructive sleep apneaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Sep 29, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 4, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 4, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 6, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 12, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 12, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 28, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance